摘要
目的探讨医院-社区-家庭一体化管理在精神分裂症患者中的应用效果。方法选择我院2018年6月—2019年6月期间收治的精神分裂症患者86例,按随机数字表法分为两组,每组43例。对照组采取常规护理管理,研究组实施医院-社区-家庭一体化管理,观察6个月。比较两组精神症状、生活质量及肇事肇祸率。结果两组管理前阳性与阴性症状量表(PANSS)评分、WHOQOL-100评分比较,差异无统计学意义(P>0.05);两组管理后PANSS评分均低于管理前,生存质量测定量表简表(QOL-BREF)评分高于管理前,差异有统计学意义(P<0.05);研究组管理后PANSS评分为(43.23±8.11)分,低于对照组的(49.48±8.26)分,WHOQOL-100评分为(83.69±8.87)分,高于对照组的(77.25±8.54)分,差异有统计学意义(P<0.05);研究组肇事肇祸率为9.30%,低于对照组的25.58%,差异有统计学意义(P<0.05)。结论医院-社区-家庭一体化管理的实施能够减轻精神分裂症患者精神症状,提升生活质量,降低肇事肇祸率。
Objective To explore the applications of hospital community family integrated management on the quality of life and accident rate of schizophrenics.Methods 86 schizophrenics admitted to our hospital from June 2018 to June 2019 were divided into two groups according to the method of random number table,43 cases in each group.Routine nursing management was adopted in the control group and hospital community family integrated management was implemented in the study group for 6 months.The mental symptoms,quality of life and accident rate were compared between the two groups.Results There was no statistical significance in PANSS score and WHOQOL-100 score between the two groups before management(P>0.05);PANSS score of the two groups after management was lower than that before management,QOL-BREF score was higher than that before management,and the difference was statistically significant(P<0.05);PANSS score of the study group after management was(43.23±8.11),lower than that of the control group(49.48±8.26),WHOQOL-100 score was(83.69±8.87),higher than the control group(77.25±8.54),the difference was statistically significant(P<0.05);the study groupls accident rate was 9.30%,lower than that of the control group 25.58%,the difference was statistically significant(P<0.05).Conclusion The implementation of hospital community family integrated management reduces the mental symptoms of schizophrenics,improve the quality of life,and reduce the accident rate.
作者
何彩霞
黄焕新
梁淑敏
李淑萍
HE Caixia;HUANG Huanxin;LIANG Shumin;LI Shuping(Mental Hospital of Guangzhou Civil Affairs Bureau,Guangzhou 510430,China)
出处
《广州医药》
2020年第6期86-89,共4页
Guangzhou Medical Journal